Sadly, Mr. Speaker, Canadians have had to rely on the EU for accurate information on the Canada-European trade agreement.
The latest CETA version, reportedly now on the Prime Minister's desk, is said to accept European patent protection and therefore impose additional drug costs on Canadians in the range of between $900 million and $1.9 billion.
Will the Prime Minister be honest with Canadians? Is it his intent to sign an agreement that will result in higher drug costs for Canadians?